<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - § 48–902.04. Schedule I enumerated.</title>
    <meta property="st:title" content="§ 48–902.04. Schedule I enumerated."/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/reset.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/site.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/body.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <link rel="stylesheet" type="text/css" href="/css/icons/style.css" media="screen"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/code/">Code of the District of Columbia</a>
        </h1>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li>↪ <a href="/">D.C. Law Library</a></li>
            <li>↪ <a href="/dc/council/code/">Code of the District of Columbia</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/">Title 48. Foods and Drugs.</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/chapters/9/">Chapter 9. Controlled Substances Act.</a></li>
            <li>↪ <a href="/dc/council/code/titles/48/chapters/9/subchapters/II/">Subchapter II. Standards and Schedules.</a></li>
            <li>↪ § 48–902.04. Schedule I enumerated.</li>
          </ul>
          <h2>Previous</h2>
          <p>
            <a href="/dc/council/code/sections/48-902.03.html">§ 48–902.03. Schedule I tests.</a>
          </p>
          <h2>Next</h2>
          <p>
            <a href="/dc/council/code/sections/48-902.05.html">§ 48–902.05. Schedule II tests.</a>
          </p>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/code/sections/48-902.04.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/code/sections/48-902.04.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body"><h1>§ 48–902.04. Schedule I enumerated.</h1> <section class="content"><section><section class="line-group primary-content"><p>The controlled substances listed in this section are included in Schedule I, unless and until removed therefrom pursuant to § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>:</p><p class="text-indent-1"><span class="level-num">(1)</span> Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers and salts is possible within the specific chemical designation:</p><p class="text-indent-2"><span class="level-num">(A)</span> Acetylmethadol;</p><p class="text-indent-2"><span class="level-num">(B)</span> Allylprodine;</p><p class="text-indent-2"><span class="level-num">(C)</span> Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alphaacetylmethadol, levomethadyl, accetate, or LAAM);</p><p class="text-indent-2"><span class="level-num">(D)</span> Alphameprodine;</p><p class="text-indent-2"><span class="level-num">(E)</span> Alphamethadol;</p><p class="text-indent-2"><span class="level-num">(F)</span> Benzethidine;</p><p class="text-indent-2"><span class="level-num">(G)</span> Betacetylmethadol;</p><p class="text-indent-2"><span class="level-num">(H)</span> Betameprodine;</p><p class="text-indent-2"><span class="level-num">(I)</span> Betamethadol;</p><p class="text-indent-2"><span class="level-num">(J)</span> Betaprodine;</p><p class="text-indent-2"><span class="level-num">(K)</span> Clonitazene;</p><p class="text-indent-2"><span class="level-num">(L)</span> Dextromoramide;</p><p class="text-indent-2"><span class="level-num">(M)</span> Diampromide;</p><p class="text-indent-2"><span class="level-num">(N)</span> Diethylthiambutene;</p><p class="text-indent-2"><span class="level-num">(O)</span> Difenoxin;</p><p class="text-indent-2"><span class="level-num">(P)</span> Dimenoxadol;</p><p class="text-indent-2"><span class="level-num">(Q)</span> Dimepheptanol;</p><p class="text-indent-2"><span class="level-num">(R)</span> Dimethylthiambutene;</p><p class="text-indent-2"><span class="level-num">(S)</span> Dioxaphetylbutyrate;</p><p class="text-indent-2"><span class="level-num">(T)</span> Dipipanone;</p><p class="text-indent-2"><span class="level-num">(U)</span> Ethylmethylthiambutene;</p><p class="text-indent-2"><span class="level-num">(V)</span> Etonitazene;</p><p class="text-indent-2"><span class="level-num">(W)</span> Etoxeridine;</p><p class="text-indent-2"><span class="level-num">(X)</span> Furethidine;</p><p class="text-indent-2"><span class="level-num">(Y)</span> Hydroxypethidine;</p><p class="text-indent-2"><span class="level-num">(Z)</span> Ketobemidone;</p><p class="text-indent-2"><span class="level-num">(AA)</span> Levomoramide;</p><p class="text-indent-2"><span class="level-num">(BB)</span> Levophenacylmorphan;</p><p class="text-indent-2"><span class="level-num">(CC)</span> Morpheridine;</p><p class="text-indent-2"><span class="level-num">(DD)</span> Noracymethadol;</p><p class="text-indent-2"><span class="level-num">(EE)</span> Norlevorphanol;</p><p class="text-indent-2"><span class="level-num">(FF)</span> Normethadone;</p><p class="text-indent-2"><span class="level-num">(GG)</span> Norpipanone;</p><p class="text-indent-2"><span class="level-num">(HH)</span> Phenadoxone;</p><p class="text-indent-2"><span class="level-num">(II)</span> Phenampromide;</p><p class="text-indent-2"><span class="level-num">(JJ)</span> Phenomorphan;</p><p class="text-indent-2"><span class="level-num">(KK)</span> Phenoperidine;</p><p class="text-indent-2"><span class="level-num">(LL)</span> Piritramide;</p><p class="text-indent-2"><span class="level-num">(MM)</span> Proheptazine;</p><p class="text-indent-2"><span class="level-num">(NN)</span> Properidine;</p><p class="text-indent-2"><span class="level-num">(OO)</span> Propiram;</p><p class="text-indent-2"><span class="level-num">(PP)</span> Racemoramide;</p><p class="text-indent-2"><span class="level-num">(QQ)</span> Thiophene;</p><p class="text-indent-2"><span class="level-num">(RR)</span> Trimeperidine;</p><p class="text-indent-2"><span class="level-num">(SS)</span> Acetyl-Alpha-Methylfentanyl;</p><p class="text-indent-2"><span class="level-num">(TT)</span> Alphe-methylfentanyl;</p><p class="text-indent-2"><span class="level-num">(UU)</span> Alpha-Methylthiofentanyl;</p><p class="text-indent-2"><span class="level-num">(VV)</span> Beta-hydroxyfentanyl;</p><p class="text-indent-2"><span class="level-num">(WW)</span> Beta-hydroxy-3-Methylfentanyl;</p><p class="text-indent-2"><span class="level-num">(XX)</span> 3-Methylfentanyl;</p><p class="text-indent-2"><span class="level-num">(YY)</span> 3-Methylthiofentanyl;</p><p class="text-indent-2"><span class="level-num">(ZZ)</span> MPPP;</p><p class="text-indent-2"><span class="level-num">(AAA)</span> Para-flurofentanyl;</p><p class="text-indent-2"><span class="level-num">(BBB)</span> PEPAP;</p><p class="text-indent-2"><span class="level-num">(CCC)</span> Thiofentanyl; and</p><p class="text-indent-2"><span class="level-num">(DDD)</span> Tilidine;</p><p class="text-indent-1"><span class="level-num">(2)</span> Unless specifically excepted or unless listed in another schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:</p><p class="text-indent-2"><span class="level-num">(A)</span> Acetorphine;</p><p class="text-indent-2"><span class="level-num">(B)</span> Acetyldihydrocodeine;</p><p class="text-indent-2"><span class="level-num">(C)</span> Benzylmorphine;</p><p class="text-indent-2"><span class="level-num">(D)</span> Codeine methylbromide;</p><p class="text-indent-2"><span class="level-num">(E)</span> Codeine-N-Oxide;</p><p class="text-indent-2"><span class="level-num">(F)</span> Cyprenorphine;</p><p class="text-indent-2"><span class="level-num">(G)</span> Desomorphine;</p><p class="text-indent-2"><span class="level-num">(H)</span> Dihydromorphine;</p><p class="text-indent-2"><span class="level-num">(I)</span> Drotepanol;</p><p class="text-indent-2"><span class="level-num">(J)</span> Etorphine (except hydrochloride salt);</p><p class="text-indent-2"><span class="level-num">(K)</span> Diacetylated morphine (heroin);</p><p class="text-indent-2"><span class="level-num">(L)</span> Hydromorphinol;</p><p class="text-indent-2"><span class="level-num">(M)</span> Methyldesorphine;</p><p class="text-indent-2"><span class="level-num">(N)</span> Methyldihydromorphine;</p><p class="text-indent-2"><span class="level-num">(O)</span> Morphine methylbromide;</p><p class="text-indent-2"><span class="level-num">(P)</span> Morphine methylsulfonate;</p><p class="text-indent-2"><span class="level-num">(Q)</span> Morphine-N-Oxide;</p><p class="text-indent-2"><span class="level-num">(R)</span> Myrophine;</p><p class="text-indent-2"><span class="level-num">(S)</span> Nicocodeine;</p><p class="text-indent-2"><span class="level-num">(T)</span> Nicomorphine;</p><p class="text-indent-2"><span class="level-num">(U)</span> Normorphine;</p><p class="text-indent-2"><span class="level-num">(V)</span> Pholcodine; and</p><p class="text-indent-2"><span class="level-num">(W)</span> Thebacon;</p><p class="text-indent-1"><span class="level-num">(3)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, its salts, isomers and salts of isomers, whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation (for purposes of this paragraph only, the term “isomer” includes the optical, position, and geometric isomers):</p><p class="text-indent-2"><span class="level-num">(A)</span> 4-bromo-2, 5-dimethoxyamphetamine;</p><p class="text-indent-2"><span class="level-num">(B)</span> 2, 5 dimethoxyamphetamine;</p><p class="text-indent-2"><span class="level-num">(C)</span> 4-methoxyamphetamine;</p><p class="text-indent-2"><span class="level-num">(D)</span> 5-methoxy-3, 4-methylenedioxy amphetamine;</p><p class="text-indent-2"><span class="level-num">(E)</span> 4-methyl-2,5-dimethoxyamphetamine;</p><p class="text-indent-2"><span class="level-num">(F)</span> 3,4-methylenedioxyamphetamine [MDA];</p><p class="text-indent-2"><span class="level-num">(G)</span> 3, 4, 5-trimethoxy amphetamine;</p><p class="text-indent-2"><span class="level-num">(H)</span> Bufotenine;</p><p class="text-indent-2"><span class="level-num">(I)</span> Diethyltryptamine;</p><p class="text-indent-2"><span class="level-num">(J)</span> Dimethyltryptamine;</p><p class="text-indent-2"><span class="level-num">(K)</span> Ethylamide analog of phencyclidine, PCE;</p><p class="text-indent-2"><span class="level-num">(L)</span> Ibogaine;</p><p class="text-indent-2"><span class="level-num">(M)</span> Lysergic acid diethylamide;</p><p class="text-indent-2"><span class="level-num">(N)</span> Mescaline;</p><p class="text-indent-2"><span class="level-num">(O)</span> Peyote;</p><p class="text-indent-2"><span class="level-num">(P)</span> N-ethyl-3-piperidyl benzilate;</p><p class="text-indent-2"><span class="level-num">(Q)</span> N-methyl-3-piperidyl benzilate;</p><p class="text-indent-2"><span class="level-num">(R)</span> Psilocybin;</p><p class="text-indent-2"><span class="level-num">(S)</span> Psilocyn;</p><p class="text-indent-2"><span class="level-num">(T)</span> Pyrrolidine analog of phencyclidine, PCPY;</p><p class="text-indent-2"><span class="level-num">(U)</span> Thiophene analog of phencyclidine;</p><p class="text-indent-2"><span class="level-num">(V)</span> Repealed;</p><p class="text-indent-2"><span class="level-num">(W)</span> Parahexyl;</p><p class="text-indent-2"><span class="level-num">(X)</span> 4-bromo-2,5-dimethoxyphenethylamine;</p><p class="text-indent-2"><span class="level-num">(Y)</span> 3,4-methylenedioxymethamphetamine [MDMA];</p><p class="text-indent-2"><span class="level-num">(Z)</span> Alpha-methyltryptamine (other name: AMT);</p><p class="text-indent-2"><span class="level-num">(AA)</span> 5-methoxy-N,N-diisopropyltryptamine (other name: 5- MeO-DIPT);</p><p class="text-indent-2"><span class="level-num">(BB)</span> 2,5-dimethoxy-4-(n)-propylthiophenethylamine (other name: 2C-T-7);</p><p class="text-indent-2"><span class="level-num">(CC)</span> 2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);</p><p class="text-indent-2"><span class="level-num">(DD)</span> 2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);</p><p class="text-indent-2"><span class="level-num">(EE)</span> 2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);</p><p class="text-indent-2"><span class="level-num">(FF)</span> 2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);</p><p class="text-indent-2"><span class="level-num">(GG)</span> 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine (2C-T-2);</p><p class="text-indent-2"><span class="level-num">(HH)</span> 2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine (2C- T-4);</p><p class="text-indent-2"><span class="level-num">(II)</span> 2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);</p><p class="text-indent-2"><span class="level-num">(JJ)</span> 2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N); and</p><p class="text-indent-2"><span class="level-num">(KK)</span> 2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);</p><p class="text-indent-1"><span class="level-num">(4)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, or mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:</p><p class="text-indent-2"><span class="level-num">(A)</span> Mecloqualone;</p><p class="text-indent-2"><span class="level-num">(B)</span> Methaqualone; and</p><p class="text-indent-2"><span class="level-num">(C)</span> Gamma-hydroxybutyric acid (some other names include GHB; gamma-hydroxybutyrate; 4-hydroxybutyrate; 4-hydroxybutanoic acid; sodium oxybate; sodium oxybutyrate);</p><p class="text-indent-1"><span class="level-num">(5)</span> Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including their analogues or derivatives and its salts, isomers, and salts of isomers:</p><p class="text-indent-2"><span class="level-num">(A)</span> Fenethyline;</p><p class="text-indent-2"><span class="level-num">(B)</span> N-ethylamphetamine;</p><p class="text-indent-2"><span class="level-num">(C)</span> Cathinone;</p><p class="text-indent-2"><span class="level-num">(D)</span> N-Benzylpiperazine (some other names: BZP, 1- benzylpiperazine);</p><p class="text-indent-2"><span class="level-num">(E)</span> Methcathinone (Some other names: 2-(methylamino)- propiophenone; alpha-(methylamino)propiophenone; 2-(methylamino)-1-phenylpropan-1- one; alpha- -methylaminopropiophenone; monomethylpropion; ephedrone; — methylcathinone; methylcathinone; AL-464; AL-422; AL-463 and UR1432), its salts, optical isomers and salts of optical isomers, as well as synthetic substances, derivatives, and their isomers with similar chemical structure and pharmacological activity to methcathinone;</p><p class="text-indent-2"><span class="level-num">(F)</span> 4-methyl-N-methylcathinone (other name: mephedrone);</p><p class="text-indent-2"><span class="level-num">(G)</span> 3,4-methylenedioxypyrovalerone (other name: MDPV); and</p><p class="text-indent-2"><span class="level-num">(H)</span> 3,4-methylenedioxy-N-methylcathinone (other name: methylone).</p></section><br/><section class="line-group annotations"><p>
      (<a class="internal-link" href="/dc/council/laws/4-29.html#§204">Aug. 5, 1981, D.C. Law 4-29, § 204, 28 DCR 3081</a>; amended by rule, 39 DCR 1882; amended by rule, Dec. 7, 1994, 41 DCR 7967; <a class="internal-link" href="/dc/council/laws/13-99.html">May 9, 2000, D.C. Law 13-99, § 2(a), 47 DCR 791</a>; <a class="internal-link" href="/dc/council/laws/18-88.html">Dec. 10, 2009, D.C. Law 18-88, § 225, 56 DCR 7413</a>; <a class="internal-link" href="/dc/council/laws/19-320.html">June 19, 2013, D.C. Law 19-320, § 301(b), 60 DCR 3390</a>.)
    </p><h4>Prior Codifications</h4><p>1981 Ed., § 33-514.</p><h4>Section References</h4><p>This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/7-3002.html">7-3002</a>, § <a class="internal-link" href="/dc/council/code/sections/44-1201.html">44-1201</a>, § <a class="internal-link" href="/dc/council/code/sections/48-901.02.html">48-901.02</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.01.html">48-902.01</a>, § <a class="internal-link" href="/dc/council/code/sections/48-902.02.html">48-902.02</a>, § <a class="internal-link" href="/dc/council/code/sections/48-1004.html">48-1004</a>, and § <a class="internal-link" href="/dc/council/code/sections/50-2206.13.html">50-2206.13</a>.</p><h4>Effect of Amendments</h4><p><a class="internal-link" href="/dc/council/laws/13-99.html">D.C. Law 13-99</a> corrected the way in which two chemicals were stated in subsec. (3) and added provisions contained in (X) and (Y) in subsec. (3).</p><p><a class="internal-link" href="/dc/council/laws/18-88.html">D.C. Law 18-88</a>, in par. (5), deleted “and” from the end of subpar. (A), substituted “; and” for a period at the end of subpar. (B), and added subpar. (C).</p><p>The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-320.html">D.C. Law 19-320</a> added (3)(Z) through (3)(KK); added (4)(C); inserted “their analogues or derivatives and” in the introductory language of (5); added (5)(D) through (5)(H); and made related changes.</p><h4>Emergency Legislation</h4><p>For temporary (90-day) amendment of section, see § 2 of the Uniform Controlled Substances Emergency Amendment Act of 1999 (D.C. Act 13-96, June 15, 1999,  46 DCR 5640).</p><p>For temporary (90-day) amendment of section, see § 2 of the Uniform Controlled Substances Congressional Review Emergency Amendment Act of 1999 (D.C. Act 13-144, October 18, 1999,  46 DCR 9904).</p><p>For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety and Justice Emergency Amendment Act of 2009 (D.C. Act 18-181, August 6, 2009,  56 DCR 6903).</p><p>For temporary (90 day) amendment of section, see § 225 of Omnibus Public Safety and Justice Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-227, October 21, 2009,  56 DCR 8668).</p><p>For temporary amendment of section, see § 301(b) of the Omnibus Public Safety and Justice Amendment Act of 2012 (D.C. Act 19-599, January 14, 2013,  60 DCR 1017).</p><p>For temporary (90 days) amendment of this section, see § 301(b) of the Omnibus Criminal Code Amendment Congressional Review Emergency Act of 2013 (D.C. Act 20-44, April 1, 2013,  60 DCR 5381, 20 DCSTAT 1281).</p><h4>Temporary Legislation</h4><p>For temporary (225 day) amendment of section, see § 2 of Uniform Controlled Substances Temporary Amendment Act of 1999 (D.C. Law 13-34, October 7, 1999, law notification  47 DCR 3423).</p><p>For temporary (225 days) amendment of this section, see <a class="internal-link" href="/dc/council/laws/21-131.html#§2(b)">§ 2(b) of Revised Synthetics Abatement and Full Enforcement Drug Control Temporary Amendment Act of 2016 (D.C. Law 21-131, July 1, 2016, 63 DCR 7110)</a>.</p></section></section></section></section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/search.js"> </script>
  </body>
</html>
